Evaxion Biotech A/S (EVAX) Free Cash Flow (2019 - 2026)
Evaxion Biotech A/S (EVAX) free cash flow from Dec 31, 2019 to Mar 31, 2026. The TTM Evaxion Biotech A/S (EVAX) free cash flow is -$6.66M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Evaxion Biotech A/S (EVAX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -27.97% |
| 5 Years TTM | -13.99% |
| All Time TTM | -11.70% |
Annual Free Cash Flow change of Evaxion Biotech A/S (EVAX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | -$6.66M | -48.53% |
| 2024 | -$13M | -27.22% |
| 2023 | -$18M | -31.77% |
| 2022 | -$26M | +11.89% |
| 2021 | -$23M | +81.53% |
| 2020 | -$13M | +80.96% |
| 2019 | -$7.09M | +254.50% |
| 2018 | -$2M | N/A |
Comparison Evaxion Biotech A/S (EVAX) five years free cash flow CAGR with competitors
Evaxion Biotech A/S (EVAX) five years free cash flow CAGR is -14.02%.